1.1
Apixaban is recommended, within its marketing authorisation, as an option for preventing venous thromboembolism in adults after elective hip or knee replacement surgery.
Apixaban is recommended, within its marketing authorisation, as an option for preventing venous thromboembolism in adults after elective hip or knee replacement surgery.